US stock results analysis for Industry - Specialty Pharmaceuticals for the month ending Nov 30, 2025

Analysis of which US stocks have performed the best and worst in Industry - Specialty Pharmaceuticals for the month ending Nov 30, 2025 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current month are considered.

Stock universe
9
POSITIVE PROFIT GROWTH
11
NEGATIVE PROFIT GROWTH
0
NEUTRAL PROFIT GROWTH
55.6 %
TOTAL REVENUE GROWTH
557.9 %
TOTAL EBIDT GROWTH
39.0 %
TOTAL OPER. PROFIT GROWTH
 Positive  Negative  Pending
Stock Last Result Updated Market Capitalization Current Price Operating Revenue Qtr Revenue Growth Qtr YoY % Revenue Surprise Qtr % Net Profit Qtr Net Profit Qtr Growth YoY % Net Profit Surprise Qtr % Operating Profit Qtr Operating Profit Growth Qtr YoY % EBITDA Qtr EBITDA Qtr growth YoY % Operating Profit Margin Qtr % Operating Profit Qtr Margin% YoY Change
Usana Health Sciences Inc 05-Nov-2025 365.62 20.00 -0.10 -2.15
Argen X SE (ADR) 30-Oct-2025 52330.51 849.95 7.83 21.55
Cidara Therapeutics Inc 06-Nov-2025 6945.23 220.86 - -178.55
Niagen Bioscience Inc 04-Nov-2025 527.52 6.61 9.29 227.14
Cronos Grp Inc 06-Nov-2025 1049.13 2.74 0.11 2316.51
Enveric Biosciences Inc 14-Nov-2025 4.75 4.64 - -
Flora Growth Corp 05-Nov-2025 5.50 7.36 13.74 -469.23
Lifevantage Corp 04-Nov-2025 80.40 6.33 -13.13 -16.92
Mannatech Inc 12-Nov-2025 14.90 7.84 - -
Natural Alternatives Intl Inc 12-Nov-2025 19.83 3.21 - -
Nature`s Sunshine Products Inc 06-Nov-2025 382.10 21.84 6.68 74.75
PharmaCyte Biotech Inc 18-Dec-2025 7.80 0.77 - -
ProPhase Labs Inc 19-Nov-2025 2.55 0.61 0.00 -
AIxCrypto Holdings Inc 14-Nov-2025 13.93 2.70 - -
Revolution Medicines Inc 05-Nov-2025 15695.64 81.19 - -
Upexi Inc 12-Nov-2025 120.10 1.90 26.06 -
FitLife Brands Inc 13-Nov-2025 150.91 16.07 -1.63 -
Synergy CHC Corp 13-Nov-2025 20.82 1.85 -26.51 -
iBio Inc 12-Nov-2025 42.05 1.87 233.33 -